BCM
BML Capital Management Portfolio holdings
AUM
$131M
1-Year Return
89.45%
This Quarter Return
+77.51%
1 Year Return
+89.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$170M
AUM Growth
+$33.4M
(+24%)
Cap. Flow
+$5.23M
Cap. Flow
% of AUM
3.08%
Top 10 Holdings %
Top 10 Hldgs %
84.84%
Holding
32
New
4
Increased
11
Reduced
6
Closed
2
Top Buys
| 1 |
AN2 Therapeutics
ANTX
|
$6.15M |
| 2 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$4.12M |
| 3 |
ACHL
Achilles Therapeutics plc American Depositary Shares
ACHL
|
$3.54M |
| 4 |
Adverum Biotechnologies
ADVM
|
$2.12M |
| 5 |
Oramed Pharmaceuticals
ORMP
|
$2.04M |
Top Sells
| 1 |
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
|
$7.71M |
| 2 |
Instil Bio
TIL
|
$3.78M |
| 3 |
Athira Pharma
ATHA
|
$2.39M |
| 4 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
$2.3M |
| 5 |
Design Therapeutics
DSGN
|
$1.41M |
Sector Composition
| 1 | Healthcare | 73.51% |
| 2 | Technology | 1.04% |
| 3 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Forte Biosciences
FBRX
$137M
| $394K | 0.23% |
70,468
| – | – |
|
27
NextCure
NXTC
$13M
| $379K | 0.22% |
23,039
| – | – |
|
28
Verrica Pharmaceuticals
VRCA
$48.4M
| $261K | 0.15% |
18,000
| – | – |
|
29
HilleVax
HLVX
$105M
| $34.8K | 0.02% |
+19,760
| New | +$34.8K |
|
|
30
Athira Pharma
ATHA
$15.1M
| – | – |
-900,000
| Closed | -$2.39M |
|
|
31
Design Therapeutics
DSGN
$341M
| – | – |
-421,749
| Closed | -$1.41M |
|
32
Wingstop
WING
$8.72B
| – | – |
0
| – | – |
|